FBDIX Mutual Fund (Franklin Biotechnology Discovery Fund Class A) is managed by Franklin Templeton Investments (US) with $924.8M in net assets. FBDIX expense ratio is 1.02%, holding 94 positions across sectors including Health Care, Unknown, Financials. Inception date: 1997-09-15.

FBDIX performance shows a YTD return of 4.07%. The 1-year return is 55.26% and the 5-year return is 8.59%. FBDIX dividend yield stands at 2.04%, paid annually.

FBDIX top holdings include Gilead Sciences Inc (5.6%), Nvaesrtex Pharmaceuticals Inc (4.6%), Amgen Inc. (4.5%), Argenx Se Spon Adr Each Rep 1 Ord Shs (4.1%), Regeneron Pharmaceuticals, Inc. (4.1%). View all FBDIX holdings, sector breakdown, or dividend history.

FBDIX can be compared against other funds using the overlap calculator or side-by-side comparison tool. FBDIX alternatives are available via the screener, along with tax-loss harvesting opportunities.